Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
Summary
• Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. It is designed to enable less experienced LC-MS users to acquire critical quality attribute (CQA) data for analysis of drug product and cell culture media. The impact is to reduce human errors and enable process improvements that can ultimately translate to lower downstream costs for manufacturing and drug product prices for patients." It incorporates new pre-developed analytical workflows that further simplify the user experience for routine product and process quality measurements of at-line samples from any bioreactor system.